Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules.
- DOI
- 10.3390/biomedicines10061293
- Published
- 2022 May 31
- Container
- Biomedicines
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/biomedicines10061293,
title = {Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules.},
author = {Rinne SS and Yin W and Borras AM and Abouzayed A and Leitao CD and Vorobyeva A and Löfblom J and Ståhl S and Orlova A and Gräslund T},
year = {2022},
journal = {Biomedicines},
doi = {10.3390/biomedicines10061293},
url = {https://doi.org/10.3390/biomedicines10061293}
}RIS
TY - JOUR TI - Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules. AU - Rinne SS AU - Yin W AU - Borras AM AU - Abouzayed A AU - Leitao CD AU - Vorobyeva A AU - Löfblom J AU - Ståhl S AU - Orlova A AU - Gräslund T PY - 2022 JO - Biomedicines DO - 10.3390/biomedicines10061293 UR - https://doi.org/10.3390/biomedicines10061293 ER -
APA
SS, R., W, Y., AM, B., A, A., CD, L., A, V., J, L., S, S., A, O., & T, G. (2022). Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules.. Biomedicines. https://doi.org/10.3390/biomedicines10061293
Source records
- pubmed · retrieved 2026-09-26T20:05:51.807Z